Procedure, apparatus and detector for the determination of fractional oxygen saturation

• US 6,104,938 A
• Filed: 02/12/1998
• Issued: 08/15/2000
• Est. Priority Date: 06/12/1996
• Status: Expired due to Term

• Current Assignee: Instrumentarium Dental Incorporated (Envista Holdings Corporation)
• Original Assignee: Instrumentarium Corporation
• Inventors: Weckstrom, Kurt, Huiku, Matti
• Primary Examiner(s): Winakur, Eric F.
• Application Number:
  US09/011,625
• Time in Patent Office: 915 Days
• Field of Search: 600/310, 600/320, 600/322, 600/323, 600/326, 600/328, 600/330
• US Class Current: 600/322
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/0275 using tracers, e.g. dye dilution
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: G01N 2021/3144 for oxymetry
• CPC Class Codes: G01N 21/1717 with a modulation of one or more physical properties of the sample during the optical investigation, e.g. electro-reflectance
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427

Abstract

The invention relates to a procedure for determining the relative concentration or composition of different kinds of haemoglobin, such as oxyhaemoglobin, deoxyhaemoglobin and dyshaemoglobins, and/or dye components contained in blood in a non-invasive manner using the light absorption caused by different haemoglobin varieties and/or dye components, in which procedure light signals are transmitted at at least two predetermined wavelengths to a tissue comprised in the patient'"'"'s blood circulation, the light signal transmitted through the target under measurement and/or reflected from it is received and the proportion of the intensity of the pulsating light signal received at each wavelength is determined in relation to the total intensity of the light transmitted through the tissue or reflected from the tissue. In the procedure, the effective extinction coefficients of blood haemoglobin derivatives and/or dye components in the tissue are determined for each light signal and/or light signal pair via a mathematical transformation from blood dye component extinction coefficients consistent with the Lambert-Beer theory and the proportion of specific blood haemoglobin derivatives and/or dye components in relation to the total amount of haemoglobin contained in the blood is determined by means of the intensity of the signals received in different wavelength ranges.

Claims

1. A method for non-invasively determining the amount of a light absorbing substance in the blood of a subject, the blood having at least two light absorbing substances, said method comprising the steps of:

(A) applying light of a first wavelength to tissue of the subject containing blood to obtain a first transmitted light quantity, the first transmitted light quantity having a pulsatile component and a non-pulsatile component;

(B) applying light of a second wavelength to tissue of the subject containing blood to obtain a second transmitted light quantity, the second transmitted light quantity having a pulsatile component and a non-pulsatile component;

(C) ratioing the pulsatile component of the first transmitted light quantity to the total first transmitted light quantity and ratioing the pulsatile component of the second light quantity to the total second transmitted light quantity to obtain first and second percentage modulation quantities (% mod 1, 2 . . . );

(D) ratioing the first and second percentage modulation quantities (% mod 1, 2 . . . ) to obtain a modulation ratio quantity (Z'"'"');

(E) formulating substance concentration determining equations (Eq 8,

     9) for wavelengths corresponding to the first and second light wavelengths;

(F) altering one of a modulation ratio term (Z'"'"', Z) or extinction coefficient terms (ε

'"'"', ε

) in the equations in accordance with the percentage modulation quantities to account for the application of the light of the first and second wavelengths to the tissue as well as the blood of the subject;

(G) solving the equations for at least one selected substance present in the blood; and

(H) determining, from the solution of the equations, the amount of the selected substance in the blood.

2. The method according to claim 1, wherein step (F) is further defined as applying a function (f) to the modulation ratio quantity (Z'"'"') obtained from the transmitted light modulation percentage quantities to obtain a modulation term (Z) for use in the solution of equations formulated according to the Lambert-Beer law.

3. The method according to claim 1, wherein step (F) is further defined as applying an extinction coefficient transform (T) to substance extinction coefficients (ε

_ij) obtained in accordance with the Lambert-Beer law to provide haemoglobin extinction coefficients (ε

'"'"'_ij) for blood in tissues and wherein step (G) is further defined as solving the equations using the modulation ratio quantity term (Z'"'"') obtained from the transmitted light modulation percentage quantities.

4. The method according to claim 1, further defined as a method for determining the relative amount of a given form of haemoglobin in the blood of the subject, the blood having at least two forms of haemoglobin, wherein step (G) is further defined as solving the equations for at least one selected form of haemoglobin in the blood, and wherein step (H) is further defined as determining the relative amount of the given form of haemoglobin in the blood.

5. The method according to claim 4, wherein step (G) is further defined as solving the equations for all haemoglobin forms present in the blood.

6. The method according to claim 4, further including the step of iteratively solving the equations to determine the relative amount of a selected given form of haemoglobin.

7. The method according to claim 4, further including the steps of iteratively solving the equations and as identifying a selected given form of haemoglobin from the results of the iterative solutions.

8. The method according to claim 4, further defined as iteratively solving the equations for a given form of haemaglobin present in the blood while formulating the equations in accordance with the assumption that the amounts of one or more other forms of haemoglobin in the blood remain constant.

9. The method according to claim 4, further including the step of iteratively solving the equations for a given form of haemoglobin to determine changes over time in the amount of the given form of haemoglobin.

10. The method according to claim 1 wherein the method includes the steps of:

applying light of four different wavelengths to the tissue of the subject to provide four transmitted light quantities;

step (C) is further defined as ratioing the pulsatile and total transmitted light quantities of each of the wavelengths to obtain four percentage modulation quantities;

step (D) is further defined as ratioing the four percentage modulation quantities to obtain a plurality of modulation ratio quantities;

step (E) is further defined as formulating equations for the four different wavelengths; and

step (F) is further defined as altering the modulation ratio term (Z'"'"', Z) or extinction coefficient terms (ε

'"'"', ε

) to account for the application of light of the four wavelengths to the tissue, as well as the blood of the subject.

11. The method according to claim 10, further including the step of iteratively solving the equations and wherein one or more modulation ratios derived from selected wavelengths is/are weighted in the iterative solution of the equations.

12. The method according to claim 10, further defined as a method for determining the relative amount of a given form of haemoglobin in the blood of the subject, the blood having at least two forms of haemoglobin, wherein step (G) is further defined as solving the equation for at least one selected form of haemoglobin in the blood, and wherein step (H) is further defined as determining the relative amount of the given form of haemoglobin in the blood.

13. The method according to claim 4, or claim 12, further defined as including the step of selecting one of said wavelengths so that there is a large difference between the extinction coefficients of selected forms of haemoglobin at the one wavelength and selecting another wavelength to be at or near the isobestic point of the extinction coefficients of the selected forms of haemoglobin.

14. The method according to claim 4, or claim 12, further defined as including the step of selecting one of said wavelengths so that there is a large difference of one sign between the extinction coefficients of selected forms of haemoglobin at the one wavelength and selecting another wavelength so that there is a large difference of the opposite sign between the extinction coefficients of the selected forms of haemoglobin at the another wavelength.

15. The method according to claim 4, or claim 12, wherein the wavelengths are selected in a range of 600 nm to 1000 nm.

16. The method according to claim 15, wherein the wavelengths are selected from the following ranges:

620-650;

655-665;

680-750; and

790-1000 nm.

17. The method according to claim 16, wherein the wavelengths are selected as follows:

645;

658;

690; and

900 nm.

18. A method according to claim 16, wherein the wavelengths are selected as follows:

632, 658, 690, and 900 nm.

19. A method according to claim 15, wherein at least one of the wavelengths is below 660 nm.

20. A method according to claim 15, further including the step of iteratively solving the equations and wherein modulation ratio quantities derived from wavelengths of 660 nm, 690 nm, and 900 nm are weighted with respect to modulation ratio quantities derived from wavelengths in a range of 620-650 nm.

21. A method according to claim 15, further defined as determining the relative amount of at least one of methaemoglobin and carboxyhaemoglobin in the blood and as using light having a wavelength in a range of 620-650 nm.

22. A method according to claim 4, or 12 further defined as determining the relative amount of oxyhaemoglobin or deoxyhaemoglobin in the blood.

23. A method according to claim 4, or 12 further defined as a method for determining the relative amount of a plurality of forms of haemoglobin and as including the step of applying light having a plurality of different wavelengths, the number of different wavelengths corresponding to the number of forms of haemoglobin, the relative amounts of which are to be determined.

24. A method according to claim 23, further defined as a method for determining the relative amount of one or more of oxyhaemoglobin, deoxyhaemoglobin, and dyshaemoglobins in the blood.

25. The method according to claim 10, wherein the wavelengths are selected to optimize the determination of a given form of haemoglobin.

26. A method according to claim 1, wherein steps (A) and (B) are further defined as applying light to substantially the same blood containing tissue in both steps.

27. A method according to claim 1, wherein the modulation ratio quantity and extinction coefficient terms in the equation are altered responsive to small spectral changes in the wavelengths of the light.

28. A method according to claim 1, further defined as carrying out a calibration procedure and including the steps of obtaining modulation ratio quantities (Z'"'"') from the blood of the subject for the first and second wavelengths;

obtaining extinction coefficients and modulation ratio quantities (Z) under Lambert-Beer law conditions for the first and second wavelengths for blood having the same properties as the subject'"'"'s blood;

comparing the modulation ratio quantities (Z, Z'"'"'); and

using data from the comparison to calibrate the determination method.

29. A method according to claim 1, wherein steps (A) and (B) are further defined as passing light through tissue of the subject.

30. A method according to claim 1, wherein steps (A) and (B) are further defined as reflecting light off the tissue of the subject.

31. A sensor for use in determining the amount of one or more light absorbing substances in the blood of a subject, said sensor comprising:

a light source emitting light for application to blood containing tissue of the subject, the emitted light of said source having at least two predetermined center wavelengths;

a receiver receiving light from the tissue;

a data storage device storing extinction coefficient data, the stored data including extinction coefficients separately determined for each predetermined center wavelength and substance; and

output means for providing output signals from said sensor relating to characteristics of the light received by said receiver and the extinction coefficients stored in said data storage device.

32. A sensor according to claim 31, wherein said storage device is further defined as storing functions which are applied to signal quantities resulting from the light received by said receiver to obtain output signal quantities suitable for use in the solution of equations formulated according to the Lambert-Beer law.

33. A sensor according to claim 31, wherein said data storage device is further defined as storing an extinction coefficient transform appliable to extinction coefficients obtained in accordance with the Lambert-Beer law to provide substance extinction coefficients for blood in tissue.

34. A sensor according to in claim 31, wherein said storage device is further defined as storing sensor identification information.

35. A sensor according to claim 31, further defined as a sensor for determining the relative amount of one or more forms of haemoglobin in the blood of the subject.

36. A sensor according to claim 35, wherein said light source comprises a plurality of light emitting elements emitting light having predetermined center wavelengths, at least one of which is below 660 nm, said light emitting elements emitting light in the following wavelength ranges;

620-650 nm, 655-665 nm, 680-750 nm, and 790-1000 nm.

37. A sensor according to claim 31 further including filter means in the light path between said light source and said receiver for providing light having said at least two predetermined center wavelengths.

38. A sensor according to claim 35, including filter means in the light path between said light source and said light receiver and wherein said filter means provides light of a plurality of predetermined center wavelengths, at least one of which is below 660 nm, said filter means providing light in the following wavelength ranges;

620-650 mn, 655-665 nm, 680-750 nm, and 790-1000 nm.

39. A sensor according to claim 31, wherein said light source comprises a first set of light emitting elements and a second set of light emitting elements, and wherein said first and second sets of light emitting elements emit light in one common wavelength range.

40. A sensor according to claim 31, wherein said light source and said receiver are arranged so that said receiver receives light transmitted through the blood containing tissue.

41. A sensor according to claim 31, wherein said light source and said receiver are arranged so that said receiver receives light reflected from the blood containing tissue.

42. A sensor according to claim 31, wherein said light source produces heat and is mounted on a heat sink for maintaining the temperature of said light source below a predetermined limit.

43. A sensor according to claim 31, wherein said light source produces heat, wherein said sensor has a frame, and wherein said light source is fastened to said frame for conducting heat from said light source to said frame to maintain the temperature of the light source below a predetermined limit.

44. A sensor according to claim 31, wherein said light source has a mounting frame and wherein said light source is located in a cavity of said frame.

45. A sensor according to claim 31, further including at least one light transmitting, optical fiber coupled to at least one of said light source or receiver.

46. A sensor according to claim 31, further including attachment means for attaching the sensor to the body of the subject.

47. Measuring apparatus for determining the amount of one or more light absorbing substances in the blood of a subject, said apparatus comprising:

a light source emitting light for application to blood containing tissue of the subject, the emitted light of said source having at least two predetermined center wavelengths;

a receiver receiving light from the tissue and providing output signals responsive to the received light;

a data storage device storing extinction coefficient data, the stored data including extinction coefficients separately determined for each predetermined center wavelength and light absorbing substance;

means coupled to said receiver for processing the output signals from the receiver;

reader means coupled to said data storage device for obtaining extinction coefficient data; and

calculating means coupled to said processing means and said reader means for determining the amount of light absorbing substance in the blood.

48. Measuring apparatus according to claim 47, further defined as one for determining the relative amount of one or more forms of haemoglobin in the blood of a subject.

49. Measuring apparatus according to claim 48, further defined as one for determining the relative amount of a plurality of forms of haemoglobin in the blood of the subject and wherein said calculating means is further defined as carrying out the determination of the forms of haemoglobin on a time division basis.

50. Measuring apparatus according to claim 47, wherein said data storage device stores sensor identification information for provision to said reader means.